Correlation Between Viridian Therapeutics and Pieris Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Viridian Therapeutics and Pieris Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viridian Therapeutics and Pieris Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viridian Therapeutics and Pieris Pharmaceuticals, you can compare the effects of market volatilities on Viridian Therapeutics and Pieris Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viridian Therapeutics with a short position of Pieris Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viridian Therapeutics and Pieris Pharmaceuticals.
Diversification Opportunities for Viridian Therapeutics and Pieris Pharmaceuticals
-0.63 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Viridian and Pieris is -0.63. Overlapping area represents the amount of risk that can be diversified away by holding Viridian Therapeutics and Pieris Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pieris Pharmaceuticals and Viridian Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viridian Therapeutics are associated (or correlated) with Pieris Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pieris Pharmaceuticals has no effect on the direction of Viridian Therapeutics i.e., Viridian Therapeutics and Pieris Pharmaceuticals go up and down completely randomly.
Pair Corralation between Viridian Therapeutics and Pieris Pharmaceuticals
Given the investment horizon of 90 days Viridian Therapeutics is expected to generate 0.55 times more return on investment than Pieris Pharmaceuticals. However, Viridian Therapeutics is 1.82 times less risky than Pieris Pharmaceuticals. It trades about 0.0 of its potential returns per unit of risk. Pieris Pharmaceuticals is currently generating about 0.0 per unit of risk. If you would invest 2,684 in Viridian Therapeutics on August 24, 2024 and sell it today you would lose (722.00) from holding Viridian Therapeutics or give up 26.9% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Viridian Therapeutics vs. Pieris Pharmaceuticals
Performance |
| Timeline |
| Viridian Therapeutics |
| Pieris Pharmaceuticals |
Viridian Therapeutics and Pieris Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Viridian Therapeutics and Pieris Pharmaceuticals
The main advantage of trading using opposite Viridian Therapeutics and Pieris Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viridian Therapeutics position performs unexpectedly, Pieris Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pieris Pharmaceuticals will offset losses from the drop in Pieris Pharmaceuticals' long position.| Viridian Therapeutics vs. Nuvalent | Viridian Therapeutics vs. Arcellx | Viridian Therapeutics vs. Vaxcyte | Viridian Therapeutics vs. Crinetics Pharmaceuticals |
| Pieris Pharmaceuticals vs. Adaptimmune Therapeutics Plc | Pieris Pharmaceuticals vs. Mereo BioPharma Group | Pieris Pharmaceuticals vs. PDS Biotechnology Corp | Pieris Pharmaceuticals vs. Leap Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |